After the data of the two groups were overlapped, it was found that PTBP1 and EIF5A were highly expressed in the primary pituitary adenomas and normal control pituitary tumor cells, and SLC27A1 was highly expressed in aggressive pituitary adenomas and TMZ-treated ATt20 cells. Here, EIF5A is linked to pituitary tumor.